You are here: Home » International » News » Companies
Business Standard

We didn't delay vaccine results until after US election, says Pfizer CEO

Last week, Pfizer and BioNTech said their vaccine was more than 90% effective at preventing Covid-19, based on an initial analysis

Topics
Pfizer | Coronavirus Vaccine | 2020 US elections

Reuters 

Pfizer
Bourla had originally suggested the companies would have vaccine results by the end of October, but did not release the findings until Nov. 9, nearly a week after the election

Inc "didn't conspire with anyone" to delay release of efficacy results for the Covid-19 vaccine it developed with German partner BioNTech SE until after the U.S. presidential election, Chief Executive Albert Bourla said on Tuesday.

"The elections were always for us an artificial line. It may have been very important for the president but not for us," Bourla said at New York Times event. "I didn't receive any pressure per se on me to do something that was not appropriate ... I would never do something like that," he said.

Last week, and BioNTech said their vaccine was more than 90% effective at preventing Covid-19, based on an initial analysis.

Bourla had originally suggested the would have vaccine results by the end of October, but did not release the findings until Nov. 9, nearly a week after the election. U.S. President Donald Trump, who lost his re-election bid to Democrat Joe Biden, had repeatedly assured the public that his administration would likely identify a successful vaccine in time for the election.

The president later tweeted that "didn't have the courage to" announce its results before the election. Bourla also said the company has already hit the required safety milestone for the vaccine's Phase III trial, which is two months of follow-up data from around half of the study's roughly 44,000 participants. He said Pfizer is currently preparing that data for submission to health regulators.

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Wed, November 18 2020. 01:31 IST
RECOMMENDED FOR YOU
.